The most commonly reported adverse events (observed in 5% of clinical trial participants) were nausea, diarrhea, vomiting, constipation, abdominal pain, dyspepsia, injection-site reactions, fatigue, hypersensitivity reactions, eructation, hair loss and gastroesophageal reflux disease
When to contact your healthcare provider: Severe or persistent nausea and vomiting that prevents adequate oral intake Signs of dehydration (decreased urination, dizziness, dry mouth) Severe abdominal pain, especially if persistent or radiating to the back Symptoms of hypoglycemia if taking tirzepatide with insulin or sulfonylureas (shakiness, sweating, confusion, rapid heartbeat) Unusual injection site reactions (severe pain, swelling, redness) Intractable vomiting or inability to keep fluids down Any other concerning symptoms For future injections: Review proper injection technique with your healthcare provider or a diabetes educator before your next dose
The choice between Mounjaro and metformin should be individualized, taking into account the specific needs, side effects, and economic considerations of each patient
Exercise: A Drug-Free Approach to Lowering High Blood Pressure
Phentermine also has weaker effects on dopamine transporters, which may contribute to its mild stimulant properties and the increased alertness some users report
